Study of Daclizumab in Patients With Chronic, Persistent Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions
Asthma
Interventions
DRUG

Daclizumab

Trial Locations (18)

18045

Valley Clinical Research Center, Easton

30188

Rx Research, Woodstock

33176

Florida Center for Allergy and Asthma Reserch, Miami

53209

Allergy and Respiratory Care Center, Milwaukee

53792

University of Wisconsin Medical School, Madison

55402

Clinical Research Institute, Minneapolis

60305

Asthma and Allergy Center of Chicago, S.C., River Forest

61704

ICSL Clinical Studies, Bloomington

75231

Pharmaceutical Research and Consulting, Inc., Dallas

80206

National Jewish Medical and Research Center, Denver

80230

Clinical Reserch Centers of Colorado, Denver

90806

Medical Research Associates, Long Beach

92120

Institute of Health Care Assessment, Inc., San Diego

92691

Southern California Research, Mission Viejo

95207

Bensch Research Associates, Stockton

97035

Allergy, Asthma, and Dermatology Research Center, LLC, Lake Oswego

02747

New England Clinical Studies, North Dartmouth

08540

Princeton Center for Clinical Research, Princeton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Facet Biotech

INDUSTRY